Live Monoclonal Antibodies News with Latest Updates

Live monoclonal antibodies news and developments with the latest updates. Check out current monoclonal antibodies news stories and find out what happened, what is going on with monoclonal antibodies. Recent news updates about monoclonal antibodies
New mechanism of cancer escape from immunity via EGFR-GSK3α-ARIH1 signaling
UPMC, HVHS Partner to Improve Access to COVID-19 Treatment
First patient dosed in latest stage of AGILE COVID-19 drug trial
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
Press Briefing by White House COVID-19 Response Team and Public Health Officials 17 April
Certain Cancer Patients at Risk of COVID-19 Vaccine Failure
Long-Term Care Residents Mount Antibodies to COVID Vaccines
Penn State’s industrial biotechnology ecosystem continues to bloom
New drug to regenerate lost teeth
Operationalizing COVID-19 Monoclonal Antibody Treatment
COVID-19 Treatment Reduces Risk of Hospitalization, Death
Study in ‘Nature’ concludes immunotherapy is less efficient in non-viral liver cancer
Antibody injections could become more affordable with new production method
B.1.1.7. Variant of SARS-CoV-2 Detected in Bangladesh
Antiviral launched at Emory: results vs COVID-19
UNSW alumnus awarded world’s top Brain Prize
Charity’s pharma investments raise questions around transparency and accountability
Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial
A Healthier Alternative to Antibiotics
AI predicts efficacy of breast cancer treatment directly from tumor architecture
AGILE COVID-19 drug testing platform to expand after funding boost
Groundbreaking COVID-19 treatments to be fast-tracked through clinical trials
NIH experts discuss SARS-CoV-2 viral variants
Four potential COVID-19 therapeutics enter Phase 2/3 testing in NIH ACTIV-2 trial
Clinical trial in hospitalized COVID-19 patients evaluates long-acting antibody therapy
New Biomarker May Predict Which Pancreatic Cancer Patients Respond to CD40 Immunotherapy
Building equity into vaccine distribution
Rockefeller grants commercial license for development of monoclonal antibodies for treatment of COVID-19
12 COVID-19 treatments being tested at UC Davis School of Medicine
New promising target for diabetes treatment
Queen Mary researchers to trial drug to protect against COVID-19 exposure
HHS, Pentagon Purchase Additional Doses of Regeneron’s Antibody Therapeutic to Treat Patients With Mild to Moderate COVID-19
Researchers recruiting patients for Regeneron antibody trial